期刊文献+

Aptamer核酸药物的研究进展 被引量:2

原文传递
导出
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2002年第3期295-298,共4页 Chinese Journal of Experimental and Clinical Virology
  • 相关文献

参考文献33

  • 1Ellington AD,Szostak JW.In vitro selection of RNA molecules that bind specific liganes.Nature,1990,346:818-822.
  • 2Tuerk C,Mac-Dougal WS.In vitro evolution of functional nucleic acids:high-affinity RNA ligands of HIV-1 proteins.Gene,1993,137:33-41.
  • 3Ye X,Gorin A,Ellington AD,et al.Deep penetration of an alpha-helix into a widened RNA major groove in the HIV rev peptide-RNA aptamer complex.Nat Struct Biol,1996,3:1026-1033.
  • 4Good PD,Krikos AJ,Li SX,et al.Expression of small,therapeutic RNAs in human cell nuclei.Gene Ther 1997,4:45-54.
  • 5Konopka K,Duzgunes N,Rossi J,et al.Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.J Drug Target,1998,5:247-259.
  • 6Konopka K,Lee NS,Rossi J,et al.Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.Gene,2000,255:235-244.
  • 7Lisziewicz J.Inhibition of HIV replication by regulated expression of a polymeric Tat activation response RNA decop as a strategy for gene therapy in AIDS.Proc Natl Acad Sci U S A,1993,90:8000-8004.
  • 8Sullenger BA,Gallardo HF,Ungers GE,et al.Over expression of TAR sequences renders cells resistant to HIV replication.Cell,1990,63:601-608.
  • 9Katahira M,Kobayashi S,Matsugami A,et al.Structural study of an RNA aptamer for a Tar protein complexes with ligands.Nucleic Acids Symp Ser,1999,42:269-270.
  • 10Bioizian C,Dausse E,Yurchenko L,et al.DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DAN kissing complexes.J Biol Chem,1999,274:12730-12737.

同被引文献18

  • 1刘文平,杜静玲.基于Thomson Innovation平台爆炸物核探测技术专利分析[J].图书情报工作,2012,56(S2):245-248. 被引量:6
  • 2杨水祥,胡大一,唐朝枢.基因组学研究的革命性工具——小分子RNA研究进展(一)[J].中国心血管病研究,2004,2(12):923-925. 被引量:8
  • 3王堃,刘克辛,韩国柱,孔维西,徐立栋.核糖核酸干扰的发现、机制及其在医药研究中的应用[J].中国新药与临床杂志,2005,24(7):572-576. 被引量:1
  • 4Information Kalorama.Nucleic Acid-Based Therapeutics:World Markets,Developments,and Applications[M].Market Profile,January 1,2005:599.
  • 5Business Communication Company.Inc,Antisense Products:Technology,Markets[M].BCC Research,2003.35.
  • 6Sewell KL,Richard SG,Baker BF,et al,Phase I Trial of ISIS 104838,a 2'-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor[J].The Journal of pharmacol and Experimental Therapeutics,2002,303:1334-1343.
  • 7Backman C,Zhang Y,Hoffer BJ.Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markers[J].Neurosci Methods,2003,131(1-2):51-56.
  • 8Xiao Feng Qin,Dong Sung An,Irvin SY,et al.Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5[J].Proc Natl Acad Sci,2003,(1):183-188.
  • 9Gitlin L,Karelsky S,Andino R.Short interfering RNA confers intracellular antiviral immunity in human cells[J].Nature,2002,418(6896):430-434.
  • 10Carthew RW.RNA interference:the fragile X syndrome connection[J].Curr Biol,2002,12(24):852-854.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部